In vivo PET imaging after injection of this tracer demonstrated much higher tumor uptake in PD-L1-positive LOX tumor-bearing mice than in PD-L1-negative SUDHL6-xenografted mice (7:1%ID/g ratio at 90 min p.i.). Here, LOX is linked to neoplasm.